)
)
Organogenesis Investor Relations Material
Latest events
Q4 2024
Organogenesis
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Organogenesis Holdings Inc
Access all reports
Organogenesis Holdings Inc. is a regenerative medicine company focused on the development, manufacturing, and commercialization of products for the advanced wound care and surgical biologics markets. The company's portfolio includes skin substitutes and other tissue-based products designed to promote healing and tissue regeneration. Organogenesis serves healthcare providers, offering solutions for the treatment of chronic and acute wounds, as well as products used in surgical and sports medicine applications. The company is headquartered in Canton, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
ORGO
Country
🇺🇸 United States